Chuck Casamento

(Mr. Charles Casamento)

Currently holds positions in Relmada Therapeutics Inc, Astex Pharmaceuticals Inc and AzurRx BioPharma Inc

Positions

Position Company Period
Independent Chairman of the Board Relmada Therapeutics Inc June 15, 2017 -
Independent Director Astex Pharmaceuticals Inc Jan. 1, 2007 -
Independent Director AzurRx BioPharma Inc March 1, 2017 -
Executive Director and Principal, The Sage Group International Stem Cell Corp June 1, 2010 - June 21, 2018
Independent Director Relmada Therapeutics Inc July 14, 2015 - June 15, 2017
Independent Director Vivus Inc April 17, 2008 - July 19, 2013
Chairman of the Board RespireRx Pharmaceuticals Inc Aug. 10, 2012 - March 22, 2013
Independent Director RespireRx Pharmaceuticals Inc July 1, 1997 - Aug. 10, 2012
Chuck Casamento's trades of Relmada Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-11 2024-09-09
B Purchase
13,000 +inf%
2.56
USD 33,280 		13,000 +inf% 2.56 USD 33,280
2023-09-18 2023-09-15
S Sale
10 -0.2%
0.43
USD 4 		10 -0.2% 0.43 USD 4
2023-09-05 2023-08-31
S Sale
6,053 -49.8%
0.30
USD 1,816 		6,053 -49.8% 0.30 USD 1,816
2022-04-05 2022-04-01
PS Planned sale
3,300 -100.0%
29.00
USD 95,700 		3,300 -100.0% 29.00 USD 95,700
2022-04-05 2022-04-01
PS Planned sale
3,300 -50.0%
29.00
USD 95,700 		3,300 -50.0% 29.00 USD 95,700
2022-04-05 2022-04-01
PS Planned sale
3,300 -33.3%
29.00
USD 95,700 		3,300 -33.3% 29.00 USD 95,700
2022-04-05 2022-04-01
PS Planned sale
3,300 -25.0%
29.00
USD 95,700 		3,300 -25.0% 29.00 USD 95,700
2022-04-05 2022-04-01
PS Planned sale
3,300 -20.0%
29.00
USD 95,700 		3,300 -20.0% 29.00 USD 95,700
2022-04-05 2022-04-01
PS Planned sale
3,300 -16.7%
29.00
USD 95,700 		3,300 -16.7% 29.00 USD 95,700
2021-06-02 2021-06-01
PS Planned sale
2,480 -26.3%
33.19
USD 82,300 		2,480 -26.3% 33.19 USD 82,300
2021-06-02 2021-06-01
PS Planned sale
520 -5.2%
34.08
USD 17,721 		520 -5.2% 34.08 USD 17,721
2021-04-05 2021-04-01
PS Planned sale
1,691 -11.5%
35.04
USD 59,253 		1,691 -11.5% 35.04 USD 59,253
2021-04-05 2021-04-01
PS Planned sale
1,309 -8.2%
35.93
USD 47,028 		1,309 -8.2% 35.93 USD 47,028
2021-03-02 2021-03-01
PS Planned sale
3,000 -15.8%
33.87
USD 101,618 		3,000 -15.8% 33.87 USD 101,618
2021-02-02 2021-02-01
PS Planned sale
1,663 -8.1%
33.90
USD 56,376 		1,663 -8.1% 33.90 USD 56,376
2021-02-02 2021-02-01
PS Planned sale
1,337 -6.1%
33.30
USD 44,522 		1,337 -6.1% 33.30 USD 44,522
2021-01-05 2021-01-04
PS Planned sale
3,000 -12.0%
32.11
USD 96,342 		3,000 -12.0% 32.11 USD 96,342
2020-12-02 2020-12-01
PS Planned sale
3,000 -10.7%
35.74
USD 107,219 		3,000 -10.7% 35.74 USD 107,219
2020-11-03 2020-11-02
PS Planned sale
3,000 -5.8%
30.29
USD 90,864 		3,000 -5.8% 30.29 USD 90,864
2020-10-02 2020-10-01
PS Planned sale
3,000 -5.4%
37.99
USD 113,956 		3,000 -5.4% 37.99 USD 113,956
2020-09-02 2020-09-01
PS Planned sale
3,000 -5.2%
34.74
USD 104,207 		3,000 -5.2% 34.74 USD 104,207
2020-08-04 2020-08-03
PS Planned sale
3,000 -8.1%
35.74
USD 107,213 		3,000 -8.1% 35.74 USD 107,213
2020-07-02 2020-07-01
PS Planned sale
3,000 -7.5%
43.89
USD 131,677 		3,000 -7.5% 43.89 USD 131,677
2019-01-02 2018-12-28
B Purchase
9,000 +18.9%
1.41
USD 12,690 		9,000 +18.9% 1.41 USD 12,690
// ... existing code ... // ... rest of the file ...